Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,116 | 102,271 | 26,001 | 46,345 | 18,834 |
| Marketable Securities | 197,311 | 154,468 | 79,936 | 92,012 | 117,369 |
| Receivables | 318 | 685 | 261 | 28 | 39 |
| Inventories | 336 | 172 | N/A | N/A | N/A |
| TOTAL | $223,372 | $263,720 | $109,546 | $140,866 | $139,063 |
| Non-Current Assets | |||||
| PPE Net | 2,134 | 2,202 | 2,207 | 2,071 | 932 |
| Intangibles | 44,543 | 44,543 | 44,543 | 44,543 | 44,543 |
| Other Non-Current Assets | 6,430 | 6,259 | 6,420 | 6,819 | 7,147 |
| TOTAL | $53,107 | $53,004 | $53,170 | $53,433 | $52,622 |
| Total Assets | $276,479 | $316,724 | $162,716 | $194,299 | $191,685 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,036 | 10,501 | 10,311 | 10,395 | 9,427 |
| Accrued Expenses | 20,225 | 15,608 | 10,060 | 12,777 | 9,018 |
| TOTAL | $32,261 | $26,109 | $20,371 | $23,172 | $18,445 |
| Non-Current Liabilities | |||||
| Long Term Debt | 99,265 | 98,772 | 48,845 | 48,579 | 23,784 |
| Other Non-Current Liabilities | 5,443 | 5,482 | 5,454 | 5,424 | 5,438 |
| TOTAL | $104,708 | $104,254 | $54,299 | $54,003 | $29,222 |
| Total Liabilities | $136,969 | $130,363 | $74,670 | $77,175 | $47,667 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 244,925 | 244,925 | 189,562 | 188,726 | 188,726 |
| Common Shares | 245 | 245 | 190 | 189 | 189 |
| Retained earnings | -1,717,083 | -1,666,558 | -1,621,654 | -1,589,720 | -1,559,226 |
| Other shareholders' equity | 2 | 15 | -48 | -489 | -552 |
| TOTAL | $139,510 | $186,361 | $88,046 | $117,124 | $144,018 |
| Total Liabilities And Equity | $276,479 | $316,724 | $162,716 | $194,299 | $191,685 |